mAbxience, a majority-owned company of German drug maker Fresenius Kabi, also has partial ownership from Insud Pharma, will be responsible ...

India Ratings and Research (Ind-Ra) said it has upgraded Tata Steel's long-term issuer rating to 'AA+' from 'AA'.

Glenmark chairman and managing director Glenn Saldanha said one of the corporate objectives of the Mumbai-headquartered company is to do at...

Donald Trump vowed in March to make the affordable medication widely available to fight the pandemic, which has sickened about 2 million pe...

Here's a look at the top stocks that may hog the limelight in today's session.

In the last two months Sun Pharma has received approval for four drugs from its pipeline after a dry spell of nearly 2 years.

The drug which will be sold under the brand name Ilumya is expected to treat adults for moderate to severe plaque psoriasis, an autoimmune ...

The novel drug known as Tildrakizumab is currently under review by the US FDA and the European Medicines Agency (EMA). The value of the con...

In return, the Indian company will receive an initial upfront payment of $50 million and be eligible for development and regulatory milesto...

The Indian market is expected to open lower. Here is a list of top fifteen stocks that are likely to be in focus today.

Spain is the choice for millions of British travellers, but more and more British citizens are spending time in Spanish jails. Top 10 beach...

Drug maker Zydus Cadila on Friday announced its foray into Spain, the fifth largest pharmaceutical market in the world.

Drug maker Zydus Cadila announced its foray into Spain, the fifth largest pharmaceutical market in the world, through the acquisition of La...

Recent drug outlicensing deals by Indian pharma companies have created much hope for research initiatives in the country.

As international generics drug markets reel under increasing pricing pressure and ever-rising competition, big pharma companies are selling...

Wanbury on Monday said it has agreed to acquire Spanish drugmaker Industria Farmaceutica Cantabri’s branded generic business for Rs 240 cro...

Ranbaxy Laboratories said it has acquired Anglo-American drug maker GlaxoSmithKline’s Mundogen generic business in Spain for an undisclosed...